Newsroom

DxI 9000 Access Immunoassay Analyzer

Featured News

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient- friendly, Blood-based Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays. 

Read more
NEW
Kevin-Oreilly

Featured News

Beckman Coulter Diagnostics Appoints Kevin O’Reilly as New President

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced Kevin O’Reilly’s appointment as its new president succeeding Julie Sawyer Montgomery, who now leads Danaher Diagnostics Platform as vice president & group executive.

Read more

News Releases

Learn more about the latest news and happenings at Beckman Coulter. 

See all news releases  


  • January 30, 2024

    Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance

    Read more
  • July 25, 2023

    Beckman Coulter’s DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC

     

    Read more
  • July 25, 2023

    Beckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance

     

    Read more
  • July 19, 2023

    Beckman Coulter Connects Scopio Labs Digital Cell Morophology with Hematology Workcell Extending Automated Workflow

    Read more
Global Public Relations
Name Jeff Tarmy
Address Beckman Coulter World Headquarters
Brea California
Phone +1-617-467-7537

Stay Connected